Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical and Experimental Rheumatology

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 21586218
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions.

  2010cited by this paper
• PDGF and vessel maturation.

  2010cited by this paper
• VEGF-C regulates lymphangiogenesis and capillary stability by regulation of PDGF-B.

  2009cited by this paper
• Abnormalities in the Regulators of Angiogenesis in Patients with Scleroderma

  2009cited by this paper
• Raynaud’s Phenomenon and Plasma Endothelin: Correlations with Capillaroscopic Patterns in Systemic Sclerosis

  2009cited by this paper
• The role of the Angiopoietins in vascular morphogenesis

  2009cited by this paper
• The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis.

  2009cited by this paper
• Human leptin induces angiogenesis in vivo.

  2008cited by this paper
• More severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis?

  2008cited by this paper
• Current concepts in normal and defective angiogenesis: Implications for systemic sclerosis

  2007cited by this paper
• Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension

  2007cited by this paper
• Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis

  2007influential reference
• VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells.

  2006cited by this paper
• The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.

  2005cited by this paper
• Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement

  2005cited by this paper
• Effects of hepatocyte growth factor on the expression of type I collagen and matrix metalloproteinase-1 in normal and scleroderma dermal fibroblasts.

  2005cited by this paper
• Elevated vascular endothelial growth factor in systemic sclerosis.

  2003influential reference
• Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.

  2003cited by this paper
• The vasculopathy of Raynaud's phenomenon and scleroderma.

  2003cited by this paper
• Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers

  2002cited by this paper
• Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis.

  2000cited by this paper
• Increased levels of hepatocyte growth factor in sera of patients with systemic sclerosis.

  1999cited by this paper
• SYSTEMIC SCLEROSIS : A Vascular Perspective

  1996cited by this paper
• Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.

  1988cited by this paper
• A modified scleroderma skin scoring method.

  1986cited by this paper
• Widefield capillary microscopy. technique and rating scale for abnormalities seen in scleroderma and related disorders

  1981cited by this paper
• Wide-field capillary microscopy.

  1981cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper

• Thiazolidine derivative (LPSF/CR-35) modulates the production of IL-17A, IL-10, IL-4, TFN, CCL2 and CXCL8 in PBMC from systemic sclerosis patients

  2025cites this paper
• Examining the relationship between vascular biomarkers and both microangiopathy and cutaneous fibrosis in systemic sclerosis

  2025cites this paper
• Circulating cell adhesion molecules in systemic sclerosis: a systematic review and meta-analysis

  2024cites this paper
• Biomarkers in the evaluation of cardiac involvement in systemic sclerosis

  2024cites this paper
• Vascular endothelial growth factor as a potential biomarker in systemic sclerosis: a systematic review and meta-analysis

  2024cites this paper
• Flow Mediated Dilation in Systemic Sclerosis: Association with clinical findings, capillaroscopic patterns and endothelial circulating markers.

  2023cites this paper
• Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc

  2023cites this paper
• Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review

  2023cites this paper
• The Provenance, Providence, and Position of Endothelial Cells in Injured Spinal Cord Vascular Pathology

  2022cites this paper
• Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients

  2022cites this paper
• Association of Circulating Vascular Endothelial Growth Factor Levels With Autoimmune Diseases: A Systematic Review and Meta-Analysis

  2021cites this paper
• Serum leptin level as a diagnostic and prognostic marker in infectious diseases and sepsis

  2021cites this paper
• Comparative Preliminary Analysis of Umbilical Cord Blood-, Healthy Adult Peripheral Blood- and Myocardial Infarct Peripheral Blood-Derived Endothelial Progenitor Cells

  2021cites this paper
• Targeted proteomics of right heart adaptation to pulmonary arterial hypertension

  2020cites this paper
• Contribution to the peripheral vasculopathy and endothelial cell dysfunction by CXCL4 in Systemic Sclerosis.

  2020cites this paper
• Immunoglobulin G of systemic sclerosis patients programs a pro-inflammatory and profibrotic phenotype in monocyte-like THP-1 cells.

  2020cites this paper
• Large‐Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis

  2020cites this paper
• Markers of Endothelial Cells in Normal and Pathological Conditions

  2020cites this paper
• CXCL4 triggers monocytes and macrophages to produce PDGF-BB, culminating in fibroblast activation: Implications for systemic sclerosis.

  2020cites this paper
• Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity.

  2019cites this paper
• The Role of Vascular Endothelial Growth Factor in Systemic Sclerosis.

  2019cites this paper
• Deciphering the Potential Pharmaceutical Mechanism of GUI-ZHI-FU-LING-WAN on Systemic Sclerosis based on Systems Biology Approaches

  2019cites this paper
• Etude du remodelage du ventricule droit dans l’hypertension pulmonaire : du phénotypage approfondi à l'étude de la protéomique

  2019cites this paper
• Implication of VEGFR2 in endometriosis: A structural biological and genetic approach

  2019cites this paper
• Vascular biomarkers and digital ulcerations in systemic sclerosis: results from a randomized controlled trial of oral treprostinil (DISTOL-1)

  2019cites this paper
• Whole-Body Distribution and Clinical Association of Telangiectases in Systemic Sclerosis

  2018cites this paper
• Wenyang Huazhuo Tongluo formula inhibits fibrosis via suppressing Wnt/β-catenin signaling pathway in a Bleomycin-induced systemic sclerosis mouse model

  2018cites this paper
• Systemic sclerosis

  2018cites this paper
• Biomarkers for Pulmonary Vascular Remodeling in Systemic Sclerosis: A Pathophysiological Approach

  2018cites this paper
• Clinical associations of serum leptin and leptin/adiponectin ratio in systemic sclerosis

  2018cites this paper
• Implementation of hiPSC-ECs in thrombosis-on-a-chip devices

  2018cites this paper
• (2018). The Role of Vascular Endothelial Growth Factor in Systemic Sclerosis. Current Rheumatology Reviews

  2018cites this paper
• Novel approaches to identify biomechanisms in systemic sclerosis

  2017cites this paper
• Serum adipokines levels in patients with systemic sclerosis: A meta-analysis

  2017cites this paper
• Tie2 as a novel key factor of microangiopathy in systemic sclerosis

  2017cites this paper
• Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis

  2017cites this paper
• PDGF in organ fibrosis.

  2017cites this paper
• Markers and Biomarkers of Endothelium: When Something Is Rotten in the State

  2017cites this paper
• The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.

  2017influential citation
• Association between Functional CYP2D6 Polymorphisms and Susceptibility to Autoimmune Diseases: A Meta-Analysis

  2017cites this paper
• Biomarkers in Scleroderma: Progressing from Association to Clinical Utility

  2016cites this paper
• The Defining Characteristics of Pulmonary Arterial Hypertension

  2016cites this paper
• The Clinical Efficacy of Nailfold Capillaroscopy in Rheumatic Diseases

  2016cites this paper
• Avaliação do perfil de citocinas e quimiocinas em pacientes com esclerose sistêmica: correlação com manifestações clínicas e com resposta ao tratamento

  2016cites this paper
• The role of non-coding RNA in the development of pulmonary arterial hypertension

  2016cites this paper
• Acroosteolysis in systemic sclerosis: An insight into hypoxia-related pathogenesis.

  2016cites this paper
• Capillaroscopic findings and vascular biomarkers in systemic sclerosis: Association of low CD40L levels with late scleroderma pattern.

  2016cites this paper
• Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis.

  2015cites this paper
• Circulating adipokines and organ involvement in patients with systemic sclerosis.

  2015cites this paper
• Characterization of Soluble Biomarkers and Regulatory B Cell Subset Useful to Improve Systemic Scleroderma Clinical Diagnosis and Management

  2015cites this paper
• Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide

  2015cites this paper
• The Circulating Levels of Selenium, Zinc, Midkine, Some Inflammatory Cytokines, and Angiogenic Factors in Mitral Chordae Tendineae Rupture

  2015cites this paper
• Efficient therapy of ischaemic lesions with VEGF121-fibrin in an animal model of systemic sclerosis

  2015cites this paper
• The Efficacy of Nailfold Capillaroscopy in Patients with Raynaud's Phenomenon

  2015cites this paper
• Pathogenesis PS 83 ANGIOTENSIN RECEPTOR TYPE 1 AND ENDOTHELIN RECEPTOR TYPE A ON IMMUNE CELLSMEDIATE MIGRATION AND THE EXPRESSION OF IL-8 AND CCL 18 WHEN STIMULATED BY AUTOANTIBODIES FROM SYSTEMIC SCLEROSIS PATIENTS

  2014cites this paper
• Evaluating digital vascular perfusion and platelet dysfunction in Raynaud's phenomenon and systemic sclerosis

  2014cites this paper
• UNIVERSIDADE DE SÃO PAULO FACULDADE DE MEDICINA DE RIBEIRÃO PRETO

  2014cites this paper
• Increased Serum Hepatocyte Growth Factor (HGF) Levels in Patients with Idiopathic Pulmonary Fibrosis (IPF) or Progressive Sarcoidosis

  2014cites this paper
• [Pro-angiogenic cytokines in systemic sclerosis].

  2014cites this paper
• The influence of Multiwave Locked System (MLS) laser therapy on clinical features, microcirculatory abnormalities and selected modulators of angiogenesis in patients with Raynaud’s phenomenon

  2014cites this paper
• Inflammatory cytokines in pulmonary hypertension

  2014cites this paper
• Wybrane cytokiny proangiogennne w twardzinie układowej* Pro-angiogenic cytokines in systemic sclerosis

  2014cites this paper
• Relationship between serum leptin level and disease activity in patients with systemic sclerosis

  2014cites this paper
• The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis

  2013cites this paper
• Pulmonary Hypertension Complicating Connective Tissue Disease

  2013cites this paper
• Serum levels of leptin receptor in patients with systemic sclerosis.

  2013cites this paper
• AB0017 Association study of genetic risk variants for psoriasis in a large cohort of psoriatic arthritis, psoriasis and controls of the spanish population and association with relevant clinical subphenotypes

  2013cites this paper
• A systematic overview on the use and relevance of capillaroscopy in systemic sclerosis

  2013cites this paper
• Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis

  2013cites this paper
• Systemic sclerosis: a critical digest of the recent literature.

  2013cites this paper
• Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change.

  2013cites this paper
• Effect of endothelin inhibition on lung fibroblasts on patients with systemic sclerosis.

  2013cites this paper
• State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology?

  2013cites this paper
• Limited Cutaneous and Diffuse Cutaneous Scleroderma: Circulating Biomarkers Differentiate Lung Involvement

  2012cites this paper
• Serum leptin, resistin and TNF‐α levels in patients with systemic sclerosis: the role of adipokines in scleroderma

  2012cites this paper
• Biomarkers in systemic sclerosis.

  2010cites this paper